News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
565,626 Results
Type
Article (40965)
Company Profile (86)
Press Release (524569)
Multimedia
Podcasts (68)
Webinars (14)
Section
Business (152931)
Career Advice (2465)
Deals (28020)
Drug Delivery (107)
Drug Development (73176)
Employer Resources (142)
FDA (13840)
Job Trends (12279)
News (273230)
Policy (27287)
Tag
Academia (2547)
Academic (1)
Accelerated approval (26)
Adcomms (30)
Allergies (118)
Alliances (38607)
ALS (163)
Alzheimer's disease (1641)
Antibody-drug conjugate (ADC) (266)
Approvals (14027)
Artificial intelligence (424)
Autoimmune disease (112)
Automation (29)
Bankruptcy (312)
Best Places to Work (9969)
BIOSECURE Act (16)
Biosimilars (159)
Biotechnology (62)
Bladder cancer (142)
Brain cancer (51)
Breast cancer (566)
Cancer (4252)
Cardiovascular disease (370)
Career advice (2087)
Career pathing (36)
CAR-T (246)
CDC (45)
Cell therapy (643)
Cervical cancer (27)
Clinical research (62478)
Collaboration (1271)
Company closure (4)
Compensation (553)
Complete response letters (53)
COVID-19 (2572)
CRISPR (76)
C-suite (719)
Cystic fibrosis (116)
Data (5540)
Decentralized trials (2)
Denatured (11)
Depression (124)
Diabetes (442)
Diagnostics (5989)
Digital health (33)
Diversity (7)
Diversity, equity & inclusion (39)
Drug discovery (197)
Drug pricing (160)
Drug shortages (26)
Duchenne muscular dystrophy (211)
Earnings (58130)
Editorial (52)
Employer branding (19)
Employer resources (133)
Events (79831)
Executive appointments (948)
FDA (16462)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (7)
Frontotemporal dementia (18)
Funding (1172)
Gene editing (168)
Generative AI (38)
Gene therapy (542)
GLP-1 (909)
Government (4353)
Grass and pollen (7)
Guidances (372)
Healthcare (16143)
HIV (49)
Huntington's disease (40)
IgA nephropathy (75)
Immunology and inflammation (241)
Immuno-oncology (36)
Indications (72)
Infectious disease (2813)
Inflammatory bowel disease (169)
Inflation Reduction Act (12)
Influenza (99)
Intellectual property (201)
Interviews (531)
IPO (12790)
IRA (49)
Job creations (2610)
Job search strategy (1687)
Kidney cancer (17)
Labor market (55)
Layoffs (498)
Leadership (37)
Legal (5822)
Liver cancer (85)
Longevity (10)
Lung cancer (615)
Lymphoma (345)
Machine learning (30)
Management (51)
Manufacturing (583)
MASH (167)
Medical device (10956)
Medtech (10993)
Mergers & acquisitions (16108)
Metabolic disorders (1133)
Multiple sclerosis (137)
NASH (23)
Neurodegenerative disease (285)
Neuropsychiatric disorders (79)
Neuroscience (2734)
NextGen: Class of 2025 (5528)
Non-profit (4011)
Now hiring (50)
Obesity (518)
Opinion (264)
Ovarian cancer (146)
Pain (169)
Pancreatic cancer (192)
Parkinson's disease (245)
Partnered (27)
Patents (423)
Patient recruitment (400)
Peanut (48)
People (51995)
Pharmaceutical (20)
Pharmacy benefit managers (18)
Phase I (19225)
Phase II (27434)
Phase III (20993)
Pipeline (3790)
Policy (254)
Postmarket research (2316)
Preclinical (7893)
Press Release (61)
Prostate cancer (208)
Psychedelics (51)
Radiopharmaceuticals (234)
Rare diseases (715)
Real estate (4159)
Recruiting (59)
Regulatory (20844)
Reports (30)
Research institute (2160)
Resumes & cover letters (360)
Rett syndrome (22)
RNA editing (12)
RSV (65)
Schizophrenia (144)
Series A (198)
Series B (145)
Service/supplier (3)
Sickle cell disease (91)
Special edition (16)
Spinal muscular atrophy (152)
Sponsored (37)
Startups (2780)
State (2)
Stomach cancer (17)
Supply chain (86)
Tariffs (73)
The Weekly (56)
Vaccines (894)
Venture capital (66)
Weight loss (349)
Women's health (60)
Worklife (18)
Date
Today (54)
Last 7 days (408)
Last 30 days (1992)
Last 365 days (26706)
2025 (26607)
2024 (30701)
2023 (34520)
2022 (45065)
2021 (48409)
2020 (46745)
2019 (39825)
2018 (30158)
2017 (27060)
2016 (25768)
2015 (30118)
2014 (22591)
2013 (18334)
2012 (19592)
2011 (20620)
2010 (18223)
Location
Africa (738)
Alabama (71)
Alaska (5)
Arizona (190)
Arkansas (11)
Asia (35207)
Australia (7240)
California (8793)
Canada (2798)
China (920)
Colorado (367)
Connecticut (351)
Delaware (290)
Europe (78106)
Florida (1401)
Georgia (284)
Idaho (53)
Illinois (683)
India (51)
Indiana (428)
Iowa (17)
Japan (355)
Kansas (107)
Kentucky (28)
Louisiana (23)
Maine (57)
Maryland (1171)
Massachusetts (6049)
Michigan (271)
Minnesota (456)
Mississippi (4)
Missouri (113)
Montana (22)
Nebraska (24)
Nevada (101)
New Hampshire (70)
New Jersey (2544)
New Mexico (20)
New York (2377)
North Carolina (1116)
North Dakota (6)
Northern California (4172)
Ohio (247)
Oklahoma (10)
Oregon (28)
Pennsylvania (1796)
Puerto Rico (19)
Rhode Island (35)
South America (998)
South Carolina (54)
South Dakota (1)
Southern California (3503)
Tennessee (135)
Texas (1436)
United States (31531)
Utah (286)
Vermont (1)
Virginia (215)
Washington D.C. (63)
Washington State (722)
West Virginia (4)
Wisconsin (73)
Wyoming (2)
565,626 Results for "reshape lifesciences formally known as enteromedics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics
August 8, 2025
·
3 min read
Press Releases
Vyome Announces Nasdaq Approval of Merger with ReShape Lifesciences, Set to Begin Trading as HIND
August 14, 2025
·
3 min read
IN PARTNERSHIP WITH ELEMENT
How Supply Chain Turbulence Is Reshaping Biotech Strategy
In this episode presented by Element Materials Technology, guests Dr. Jihye Jang-Lee and Dr. Khanh Courtney discuss how small biotechs face mounting pressure amid manufacturing uncertainties.
October 23, 2025
·
1 min read
·
BioSpace Insights
Vaccines
CDC Formally Adopts Delayed Hepatitis B Vaccine Dose
The CDC accepted the recommendation of its advisory committee that the shot be delayed for many patients until they are at least two months of age due to safety concerns. The CDC itself has said the vaccine is safe and effective.
December 17, 2025
·
4 min read
·
Tristan Manalac
Press Releases
BioCardia Cell Therapy for Ischemic Heart Failure to Progress to Formal Clinical Consultation with Japan PMDA
December 17, 2025
·
7 min read
Press Releases
AB Science patent for masitinib in the treatment of sickle cell disease formally granted in the US with a protection until 2040
December 23, 2025
·
8 min read
Press Releases
Traws Pharma Adds John Leaman, MD, as Independent Director and Formalizes Appointments of Two Key Executives
October 6, 2025
·
7 min read
Press Releases
Greenwich LifeSciences Announces Completion of Enrollment in the Open Label Arm of FLAMINGO-01
December 8, 2025
·
7 min read
Press Releases
Greenwich LifeSciences Provides Additional Updates on FLAMINGO-01 and Corporate Strategy
December 23, 2025
·
11 min read
Earnings
FDA Formally Rejects Regeneron’s Eylea HD Over Manufacturing Issues
Despite the rejection, analysts saw Regeneron’s use of an alternate filler for Eylea HD as a positive development, with BMO Capital Markets noting that this could signal the end of manufacturing troubles for the franchise.
October 29, 2025
·
2 min read
·
Tristan Manalac
1 of 56,563
Next
